ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 7 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Partnership

Cipla Partnership

Cipla signed an exclusive licensing and supply agreement with SBP Group’s CTTQ for the drug Rolditamig Deuderuxtecan. This collaboration aims to accelerate therapy access in licensed markets.

Source

BSE filing, NSE: CIPLA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cipla Ltd: key numbers

Share price
₹1,411.00
Market cap
₹1,13,993 Cr
Revenue (annual)
₹28,163 Cr
Net profit (annual)
₹3,879 Cr
P/E (TTM)
39.4×Sector 43.0×
Promoter holding
29.21%+0.00% QoQ
FII holding
20.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cipla Ltd

All →

Other partnership announcements

All →
19:22 IST NSE
PartnershipdelaPlex Ltd DELAPLEX

delaPlex Partnership

Delaplex Limited announced a strategic partnership with UKG to deliver workforce management consulting and implementation across India and Asia-Pacific. No monetary value or financial impact was disclosed.

18:07 IST BSE
PartnershipEverest Kanto Cylinder Ltd EKC

Everest Kanto Cylinder Partnership

Everest Kanto's subsidiary EKC Egypt signed an MoU with CARGAS to study CNG transport unit manufacturing. No monetary value or orders have been committed yet.

Execution
One-year framework MoU, renewable for additional periods
08:55 IST BSE
PartnershipBlue Cloud Softech Solutions Ltd BLUECLOUDS

Blue Cloud Softech Solutions Partnership

Blue Cloud Softech signed an MoU with Ghana-based Kasten Development to explore business development in Ghana and Africa. No monetary value was disclosed.